The UK’s pricing regulator the National Institute of Health and Care Excellence (NICE) has revised its previous rejection of Takeda’s Alunbrig (brigatinib) for adults with anaplastic lymphoma kinase ....
Carsten Hellmann, President & CEO, said: "Christian's experience and leadership qualities make him ideally suited to his new role and I would like to congratulate him on his appointment and welcome him as a member of ALK's management team, where his exper
Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small cell lung cancer, Roche unveiled a second wave of findings at the European ...